CVS Health Cash Flow Statement
CVS / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
CVS Health generated $10.6B in operating cash flow and $7.8B in free cash flow in FY2025. Free cash flow margin was 1.9% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $1.8B | $4.6B | $8.0B | $4.3B | $6.6B | -$594.0M | $6.6B | -$594.0M | $6.6B | $5.3B | $5.2B | $4.6B | $4.6B | $3.9B | $3.5B |
| Depreciation & Amortization | $4.6B | $4.6B | $4.5B | $4.2B | $4.4B | $2.7B | $4.4B | $2.7B | $2.5B | $2.5B | $2.1B | $1.9B | $1.9B | $1.8B | $1.6B |
| Operating Cash Flow | $10.6B | $9.1B | $18.3B | $16.2B | $12.8B | $8.9B | $12.8B | $8.9B | $8.0B | $10.1B | $8.5B | $8.1B | $5.8B | $6.7B | $5.9B |
| Capital Expenditures | $2.8B | $2.8B | $2.5B | $2.7B | $2.5B | $2.0B | $2.5B | $2.0B | $1.9B | $2.2B | $2.4B | $2.1B | $2.0B | $2.0B | $1.9B |
| Free Cash Flow | $7.8B | $6.3B | $15.7B | $13.4B | $10.4B | $6.8B | $10.4B | $6.8B | $6.1B | $7.9B | $6.2B | $6.0B | $3.8B | $4.6B | $4.0B |
| Share Buybacks | $0 | $3.0B | $0 | $3.5B | - | - | $0 | $0 | $4.4B | $4.5B | $5.0B | $4.0B | $4.0B | $4.3B | $3.0B |
| Dividends Paid | $3.4B | $3.4B | $2.6B | $2.9B | $2.6B | $2.0B | $2.6B | $2.0B | $2.0B | $1.8B | $1.6B | $1.3B | $1.1B | $829.0M | $674.0M |
| FCF Margin | 1.9% | 1.7% | 5.4% | 4.2% | 4.0% | 3.5% | 4.0% | 3.5% | 3.3% | 4.5% | 4.0% | 4.3% | 3.0% | 3.8% | 3.7% |